Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Vaccine
|
December 22, 2021
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
William L Herring, Yuanhui Zhang, Vivek Shinde, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
New IPECAD Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer's Disease Treatment: Development and Use Cases
Ron Handels, William L Herring, Sabine Grimm, et al.
Vaccines
|
January 22, 2024
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States
Kyle Paret, Hadi Beyhaghi, William L Herring, et al.
Journal of Comparative Effectiveness Research
|
November 1, 2022
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes
William L Herring, Ian Gopal Gould, Villum Wittrup-Jensen, et al.
Neurology and Therapy
|
August 24, 2021
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease
William L Herring, Ian Gopal Gould, Howard Fillit, et al.
Neurology and Therapy
|
July 3, 2025
Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer's Disease: A U.S. Cost Comparison Model
Amir Abbas Tahami Monfared, Stephanie Barrows, Lindsey Fox, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 28, 2022
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study
Xiao Li, David Hodgson, Julien Flaig, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
July 1, 2021
Estimated Public Health Impact of the Recombinant Zoster Vaccine
Brandon J Patterson, Philip O Buck, Desmond Curran, et al.
Journal of Internal Medicine
|
December 15, 2023
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
Karin Wahlberg, Bengt Winblad, Amanda Cole, et al.
Journal of Medical Economics
|
July 10, 2025
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review
Olivia M Dong, Na'ngono Manga, Yue Zhong, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Vaccine
|
December 22, 2021
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
William L Herring, Yuanhui Zhang, Vivek Shinde, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
New IPECAD Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer's Disease Treatment: Development and Use Cases
Ron Handels, William L Herring, Sabine Grimm, et al.
Vaccines
|
January 22, 2024
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States
Kyle Paret, Hadi Beyhaghi, William L Herring, et al.
Journal of Comparative Effectiveness Research
|
November 1, 2022
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes
William L Herring, Ian Gopal Gould, Villum Wittrup-Jensen, et al.
Neurology and Therapy
|
August 24, 2021
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease
William L Herring, Ian Gopal Gould, Howard Fillit, et al.
Neurology and Therapy
|
July 3, 2025
Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer's Disease: A U.S. Cost Comparison Model
Amir Abbas Tahami Monfared, Stephanie Barrows, Lindsey Fox, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 28, 2022
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study
Xiao Li, David Hodgson, Julien Flaig, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
July 1, 2021
Estimated Public Health Impact of the Recombinant Zoster Vaccine
Brandon J Patterson, Philip O Buck, Desmond Curran, et al.
Journal of Internal Medicine
|
December 15, 2023
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
Karin Wahlberg, Bengt Winblad, Amanda Cole, et al.
Journal of Medical Economics
|
July 10, 2025
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review
Olivia M Dong, Na'ngono Manga, Yue Zhong, et al.
Page
of 2